Sensus Healthcare, Inc.
SRTS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $42 | $24 | $45 | $27 |
| % Growth | 71.3% | -45.2% | 64.7% | – |
| Cost of Goods Sold | $17 | $10 | $15 | $10 |
| Gross Profit | $24 | $14 | $30 | $17 |
| % Margin | 58.4% | 57.6% | 66.5% | 62.8% |
| R&D Expenses | $4 | $4 | $3 | $3 |
| G&A Expenses | $7 | $5 | $5 | $5 |
| SG&A Expenses | $12 | $11 | $11 | $9 |
| Sales & Mktg Exp. | $5 | $6 | $6 | $5 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $16 | $14 | $15 | $13 |
| Operating Income | $8 | -$0 | $15 | $4 |
| % Margin | 19.4% | -1.6% | 33.3% | 15.2% |
| Other Income/Exp. Net | $1 | $1 | $13 | -$0 |
| Pre-Tax Income | $9 | $1 | $28 | $4 |
| Tax Expense | $2 | $0 | $4 | $0 |
| Net Income | $7 | $0 | $24 | $4 |
| % Margin | 15.9% | 2% | 54.4% | 15.2% |
| EPS | 0.41 | 0.03 | 1.47 | 0.25 |
| % Growth | 1,275.8% | -98% | 488% | – |
| EPS Diluted | 0.41 | 0.03 | 1.46 | 0.25 |
| Weighted Avg Shares Out | 16 | 16 | 16 | 16 |
| Weighted Avg Shares Out Dil | 16 | 16 | 17 | 17 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $1 | $1 |
| EBITDA | $9 | $0 | $15 | $5 |
| % Margin | 20.4% | 0.3% | 34.4% | 17.5% |